Brokerages Set Phibro Animal Health Corporation (NASDAQ:PAHC) Price Target at $37.50

Phibro Animal Health Corporation (NASDAQ:PAHC) has earned an average rating of “Hold” from the six analysts that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and two have given a buy recommendation to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $37.50.

PAHC has been the subject of a number of recent analyst reports. Zacks Research cut shares of Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, February 9th. Weiss Ratings restated a “buy (b-)” rating on shares of Phibro Animal Health in a research note on Monday, December 29th. Morgan Stanley set a $49.00 price objective on shares of Phibro Animal Health in a research note on Friday, February 6th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Phibro Animal Health from $45.00 to $50.00 and gave the company an “overweight” rating in a report on Friday, November 7th.

Insider Buying and Selling at Phibro Animal Health

In other news, CEO Jack Bendheim sold 110,842 shares of the firm’s stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $48.38, for a total value of $5,362,535.96. Following the completion of the transaction, the chief executive officer directly owned 122,958 shares in the company, valued at $5,948,708.04. This trade represents a 47.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders sold 293,920 shares of company stock valued at $13,885,755 over the last quarter. 50.13% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Phibro Animal Health

Several hedge funds and other institutional investors have recently bought and sold shares of the business. 1620 Investment Advisors Inc. increased its stake in shares of Phibro Animal Health by 77.4% in the fourth quarter. 1620 Investment Advisors Inc. now owns 676 shares of the company’s stock worth $25,000 after acquiring an additional 295 shares during the period. Farther Finance Advisors LLC boosted its holdings in Phibro Animal Health by 113.2% in the fourth quarter. Farther Finance Advisors LLC now owns 727 shares of the company’s stock valued at $27,000 after purchasing an additional 386 shares during the last quarter. Rothschild Investment LLC grew its position in Phibro Animal Health by 2,500.0% during the 4th quarter. Rothschild Investment LLC now owns 1,040 shares of the company’s stock worth $39,000 after purchasing an additional 1,000 shares during the period. Hughes Financial Services LLC purchased a new position in shares of Phibro Animal Health during the 3rd quarter valued at about $40,000. Finally, iSAM Funds UK Ltd purchased a new position in shares of Phibro Animal Health during the 3rd quarter valued at about $61,000. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Stock Down 2.4%

Phibro Animal Health stock opened at $51.52 on Friday. Phibro Animal Health has a 1-year low of $16.16 and a 1-year high of $56.30. The business has a fifty day moving average price of $42.66 and a 200-day moving average price of $40.31. The company has a debt-to-equity ratio of 2.14, a current ratio of 3.05 and a quick ratio of 1.22. The stock has a market capitalization of $2.09 billion, a price-to-earnings ratio of 22.90, a PEG ratio of 0.81 and a beta of 0.80.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, February 4th. The company reported $0.87 EPS for the quarter, beating analysts’ consensus estimates of $0.69 by $0.18. The company had revenue of $373.91 million during the quarter, compared to analysts’ expectations of $355.64 million. Phibro Animal Health had a return on equity of 38.28% and a net margin of 6.29%.Phibro Animal Health has set its FY 2026 guidance at 2.930-3.100 EPS. Equities research analysts forecast that Phibro Animal Health will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 25th. Shareholders of record on Wednesday, March 4th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 0.9%. The ex-dividend date is Wednesday, March 4th. Phibro Animal Health’s payout ratio is presently 21.33%.

About Phibro Animal Health

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.